Teaching an old dog new tricks: drug repositioning in small cell lung cancer
- PMID: 24327694
- PMCID: PMC3878064
- DOI: 10.1158/2159-8290.CD-13-0790
Teaching an old dog new tricks: drug repositioning in small cell lung cancer
Abstract
Jahchan and colleagues report the use of a biostatistical analysis to identify effective therapeutics for small cell lung cancer (SCLC). Their results reveal a new use for the tricyclic antidepressant imipramine in SCLC and shed light on the therapeutic potential of drug repositioning in cancer and other diseases.
©2013 AACR.
Figures
Comment on
-
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.Cancer Discov. 2013 Dec;3(12):1364-77. doi: 10.1158/2159-8290.CD-13-0183. Epub 2013 Sep 26. Cancer Discov. 2013. PMID: 24078773 Free PMC article.
References
-
- Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. SEER Cancer Statistics Review. National Cancer Institute; 1975-2009.
-
-
Recalcitrant Cancer Research Act of 2012.
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
